HRTX logo

HRTX
Heron Therapeutics Inc

7,323
Mkt Cap
$154.49M
Volume
15,538.00
52W High
$2.61
52W Low
$0.7362
PE Ratio
-6.80
HRTX Fundamentals
Price
$0.8296
Prev Close
$0.8194
Open
$0.8303
50D MA
$1.04
Beta
1.45
Avg. Volume
2.06M
EPS (Annual)
-$0.1211
P/B
11.62
Rev/Employee
$1.21M
$311.78
Loading...
Loading...
News
all
press releases
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Zacks·3d ago
News Placeholder
More News
News Placeholder
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of "Hold" by Analysts
Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Get Free Report) have received a consensus rating of "Hold" from the five research firms that are covering the firm, MarketBeat Ratings reports. One...
MarketBeat·7d ago
News Placeholder
Q1 Earnings Forecast for HRTX Issued By Northland Securities
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Northland Securities cut their Q1 2026 EPS estimates for Heron Therapeutics in a research note issued to investors on Thursday, March 26th...
MarketBeat·11d ago
News Placeholder
What is Northland Securities' Estimate for HRTX Q3 Earnings?
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Equities research analysts at Northland Securities upped their Q3 2026 earnings estimates for shares of Heron Therapeutics in a research note...
MarketBeat·14d ago
News Placeholder
Baker BROS. Advisors LP Purchases New Position in Heron Therapeutics, Inc. $HRTX
Baker BROS. Advisors LP purchased a new stake in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·26d ago
News Placeholder
Citigroup Inc. Increases Stock Position in Heron Therapeutics, Inc. $HRTX
Citigroup Inc. boosted its position in Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 4,666.9% during the third quarter, according to the company in its most recent filing with the...
MarketBeat·1mo ago
News Placeholder
HC Wainwright Has Negative Forecast for HRTX FY2026 Earnings
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Equities research analysts at HC Wainwright reduced their FY2026 earnings per share (EPS) estimates for Heron Therapeutics in a research note...
MarketBeat·1mo ago
News Placeholder
What is Northland Securities' Forecast for HRTX Q1 Earnings?
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Northland Securities issued their Q1 2026 earnings per share (EPS) estimates for Heron Therapeutics in a research report issued on Thursday...
MarketBeat·1mo ago
News Placeholder
Heron Therapeutics (NASDAQ:HRTX) Rating Lowered to Strong Sell at Zacks Research
Zacks Research lowered Heron Therapeutics from a "hold" rating to a "strong sell" rating in a research note on Thursday...
MarketBeat·1mo ago
News Placeholder
What is HC Wainwright's Estimate for HRTX Q1 Earnings?
Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) - Investment analysts at HC Wainwright issued their Q1 2026 EPS estimates for shares of Heron Therapeutics in a research report issued to clients...
MarketBeat·1mo ago
<
1
2
...
>

Latest HRTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.